Research

Driving Drug Development for Hematologic Diseases

Relationships That Fuel Research

Our mobile, direct-to-patient approach gives you access to the difficult-to-reach populations affected by these debilitating disorders. You’ll get an all-inclusive view of each patient in your study-meaning you’ll collect more accurate data points related to the complex differences seen on an individual level. Moreover, Sanguine’s emphasis on establishing trust ensures long-term patient participation and study completion.

icons-70-x-70-hematological
  • Amyloidosis
  • Idiopathic Thrombocytopenic Purpura (ITP)
  • Sickle Cell Disease (SCD)
  • Thrombotic Thrombocytopenic Purpura (TTP)

Sanguine's Expertise in Hematology

>1,000

Patient Members

>65

Studies Completed

HEMATOLOGIC - Map

Contact us to discuss your research needs

Sanguine Services

Patient Biospecimens & Data Collection

Longitudinal & Event-Based Collection

Patient Surveys & Questionnaires

Onsite & Same-Day Healthy Control Programs

Sickle-Cell-Disease_eBook_Final

eBook

Patient-Led Biospecimen and Data Collection: A New Frontier in Sickle Cell Research

826634397

Webinar

Forging a Path for Early Clinical Development in Sickle Cell Disease

Hear From Our Community

Charly_SCD@2x

"My journey with Sanguine has been very optimistic. Whenever I get a call about a possible sickle cell disease study, I feel compelled to do it. Knowing that my participation helps with developing innovative safe treatments, and possibly a cure, I look it at as my being a superhero for our future generation. We’re more than a ‘subject’!"

Charly

email

Subscribe to our Newsletter

Select what you would like to receive directly in your email